CIK: 0001388551 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $53,181 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| USO | UNITED STS OIL FD LP | 173,500 | $11,326 | 21.3% | — | — | Call | 91232N207 |
| SVRA | SAVARA INC | 6,896,551 | $10,690 | 20.1% | $1.66 | -3.3% | COM | 805111101 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 6,039,028 | $9,421 | 17.7% | $2.16 | -23.4% | COM | 98422E103 |
| SPY | SPDR S&P 500 ETF TR | 15,947 | $5,696 | 10.7% | $451.81 | — | TR UNIT | 78462F103 |
| SCYX | SCYNEXIS INC | 1,723,947 | $4,137 | 7.8% | $6.13 | -60.1% | COM NEW | 811292200 |
| RZLT | REZOLUTE INC | 1,403,157 | $3,845 | 7.2% | $9.52 | -69.7% | COM NEW | 76200L309 |
| XOP | SPDR SER TR | 17,500 | $2,183 | 4.1% | $124.74 | — | S&P OILGAS EXP | 78468R556 |
| — | MOLECULAR TEMPLATES INC | 2,052,991 | $1,539 | 2.9% | $8.09 | — | COM | 608550109 |
| ACLX | ARCELLX INC | 76,186 | $1,430 | 2.7% | $16.24 | +17.9% | COMMON STOCK | 03940C100 |
| AMLP | ALPS ETF TR | 29,500 | $1,079 | 2.0% | $36.58 | — | ALERIAN MLP | 00162Q452 |
| — | EIGER BIOPHARMACEUTICALS INC | 116,884 | $880 | 1.7% | $9.18 | — | COM | 28249U105 |
| — | VECTIVBIO HLDG AG | 140,863 | $845 | 1.6% | $5.40 | — | ORD SHS | H9060V101 |
| — | ELEVATION ONCOLOGY INC | 68,297 | $77 | 0.1% | $9.95 | — | COM | 28623U101 |
| — | FRAZIER LIFESCIENCES ACQU CO | 21,333 | $17 | 0.0% | $0.89 | — | *W EXP 11/30/202 | G3710A113 |
| — | LUX HEALTH TECH ACQUISITION | 66,666 | $9 | 0.0% | $1.49 | — | *W EXP 11/30/202 | 55068A118 |
| — | BRIDGETOWN HOLDINGS LTD | 39,773 | $5 | 0.0% | $4.40 | — | *W EXP 09/30/202 | G1355U121 |
| — | PRIMAVERA CAPITAL ACQUIST CO | 12,000 | $2 | 0.0% | $0.83 | — | *W EXP 01/19/202 | G7255E117 |